CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Merck Sharp & Dohme B.V. v. Dr. Reddy's Laboratories, S.A.

1:15-cv-00806

📡 5G SEP • ETSI Declared

Overview

Case Number 1:15-cv-00806
Filing Date 2015-09-11
Status Terminated
Termination Date 2017-12-21
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Dr. Reddy's Laboratories, S.A. Operating Company

Represented By

4 Attorneys Listed

Robert M. Vrana

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-6600

Rodney Square, 1000 North King Street

Todd S. Werner

Email: werner@avantechlaw.com

Mark D. Schuman

UNDELIVERABLE EMAIL 8/30/2019

Caroline L. Marsili

Email: cmarsili@carlsoncaspers.com

Dr. Reddy's Laboratories Inc. Operating Company

Represented By

4 Attorneys Listed

Robert M. Vrana

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-6600

Rodney Square, 1000 North King Street

Todd S. Werner

Email: werner@avantechlaw.com

Mark D. Schuman

UNDELIVERABLE EMAIL 8/30/2019

Caroline L. Marsili

Email: cmarsili@carlsoncaspers.com

Teva Pharmaceuticals USA Inc. Operating Company

Represented By

7 Attorneys Listed

Robert M. Vrana

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-6600

Rodney Square, 1000 North King Street

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

Andrew Russell

Shaw Keller LLP

Tel: +1 (302) 298-0704

1105 North Market St., 12th Floor, I. M. Pei Building

Todd S. Werner

Email: werner@avantechlaw.com

John W. Shaw

Shaw Keller LLP

Tel: +1 (302) 298-0701

I.M. Pei Building, 1105 North Market Street

Mark D. Schuman

UNDELIVERABLE EMAIL 8/30/2019

Caroline L. Marsili

Email: cmarsili@carlsoncaspers.com

Teva Pharmaceutical Industries Ltd. Operating Company

Represented By

2 Attorneys Listed

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

John W. Shaw

Shaw Keller LLP

Tel: +1 (302) 298-0701

I.M. Pei Building, 1105 North Market Street

Plaintiff

Merck Sharp & Dohme B.V. Operating Company

Represented By

3 Attorneys Listed

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Mary B. Graham

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Thomas J. Curry

Labaton Sucharow LLP

Tel: +1 (302) 573-6956

300 Delaware Avenue, Suite 1340

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 2 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 1 proceeding
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (2): 🇪🇺 Europe 🇺🇸 US
Parallel Proceedings Across Jurisdictions (1 found):
U.S. Courts: 1
U.S. District Court 2013-12-24
1:13-cv-02088

Merck Sharp & Dohme B.V. v. Warner Chilcott Company LLC

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Standard Essential Patent (SEP) & FRAND Intelligence

5G SEP • ETSI Declared High-Probability SEP Action

Essential standard specifications, SSO declaration status, and FRAND antitrust defense evaluation

FRAND Encumbered
Essential Standard 4G / 5G LTE Generation: 5G
Standard Setting Org (SSO) ETSI / 3GPP Essential specification under ETSI / 3GPP governance
FRAND Commitment Committed Fair, Reasonable & Non-Discrim.
Known Patent Pools Avanci / Sisvel / Via Licensing Coverage Applicable Declarant: Sharp

Injunction Restrictions & FRAND Defense Leverage (CJEU Huawei v. ZTE Framework)

Permanent Injunction Restricted

Asserted by recognized SEP declarant. Under the CJEU Huawei v. ZTE test, injunctions are barred if the defendant qualifies as a willing licensee.

✓ Patentee bound by SSO IPR Policy (ETSI Annex 6 / IEEE Patent Policy).
✓ Right to demand global FRAND portfolio determination.
✓ Non-discrimination defense: check licensing terms offered to competing implementers.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US5989581
Drug delivery system for two or more active substances
Filed: 1998-04-08
Issued: 1999-11-23
Expired (Term Ended)
Expires: 2018-04-08

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

11

Dispositive

6

Granted

1

Denied

0

Pending / Review

10

Motions by Category

Procedural / Extension Motion 2 Claim Construction / Markman Filing 1 Motion to Dismiss 6 Motion to Stay 2

Key Dispositive Motions & Rulings

Motion to Dismiss Granted
ORDER, that Defendant's motion to dismiss the Complaint (D.I. 13 ) is GRANTED and Plaintiff's motion to stay the case (D.I. 32 ) is DENIED. In light of decision...
Entry #42 • 2016-11-28 Document →
Motion to Dismiss Pending / Under Review
Letter to The Honorable Kent A. Jordan from Robert M. Vrana regarding Motion to Dismiss - re 39 Letter. (Vrana, Robert) (Entered: 11/16/2016)
Entry #41 • 2016-11-16 Document →
Motion to Dismiss Pending / Under Review
Letter to The Honorable Kent A. Jordan from Robert M. Vrana regarding Defendants' Motion to Dismiss (D.I. 31) - re 31 MOTION to Dismiss Based upon Collateral Es...
Entry #39 • 2016-11-14 Document →
Motion to Dismiss Pending / Under Review
REPLY BRIEF re 31 MOTION to Dismiss Based upon Collateral Estoppel filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, S.A.. (Vrana, Robert) (Ente...
Entry #36 • 2016-10-21 Document →
Motion to Dismiss Pending / Under Review
ANSWERING BRIEF in Opposition re 32 MOTION to Stay Proceedings, 31 MOTION to Dismiss Based upon Collateral Estoppel filed by Merck Sharp & Dohme B.V..Reply Brie...
Entry #33 • 2016-10-13 Document →
Motion to Dismiss Pending / Under Review
MOTION to Dismiss Based upon Collateral Estoppel - filed by Teva Pharmaceuticals USA Inc.. (Attachments: # 1 Text of Proposed Order)(Vrana, Robert) (Entered: 09...
Entry #31 • 2016-09-26 Document →

Docket Entries

(61 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1785537.) - filed by Merck Sharp & Dohme B.V.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(dmp, ) (Entered: 09/11/2015)

Entry #1 • 2015-09-11
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (dmp, ) (Entered: 09/11/2015)

Entry #2 • 2015-09-11
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: On or about July 27, 2015. Date of Expiration of Patent: April 8, 2018. Thirty Month Stay Deadline: Not Applicable. (dmp, ) (Entered: 09/11/2015)

Entry #3 • 2015-09-11
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,989,581;. (dmp, ) (Entered: 09/11/2015)

Entry #4 • 2015-09-11
1
Pleading / Complaint

SUMMONS Returned Executed by Merck Sharp & Dohme B.V.. Teva Pharmaceuticals USA Inc. served on 9/11/2015, answer due 10/2/2015. (Graham, Mary) (Entered: 09/14/2015)

Entry #5 • 2015-09-14
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc